Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | SVP, Regions & Chf SupChn Ofcr | February 24, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.12 · Expires 2036-02-23 | Direct | 24,364 |
Reported balance
After 2026-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-24 · Grant · Acquired 24,364 · Balance 24,364 F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,352 |
Reported balance
After 2026-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-24 · Grant · Acquired 3,352 · Balance 3,352 F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 26, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 3,352 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000065 · wk-form4_1772139800.xml · derivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,352 Underlying: Common Stock · 3,352 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 24,364 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000915389-26-000065 · wk-form4_1772139800.xml · derivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,364 Underlying: Common Stock · 24,364 shares Expires 2036-02-23 F1 · derivative.exercise_date: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 1,812 | $80.26 | $145,431.12 |
DisclosureSEC source: 0000915389-26-000046 · wk-form4_1771621415.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,199 F1 · shares: Shares of common stock withheld in payment of tax obligations related to the payout of performance shares for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 7,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000026 · wk-form4_1771016542.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,011 F1 · shares: Determination of the number of performance shares earned for the three-year (2023- 2025) performance period. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 20:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | PurchaseCommon Stock | 2,000 | $68.43 | $136,858.80 |
DisclosureSEC source: 0001571482-25-000003 · wk-form4_1756411575.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,731 Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 2,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000048 · wk-form4_1740431994.xml · derivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,430 Underlying: Common Stock · 2,430 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issue common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 12,725 | $0.00 Strike: $100.56 | $0.00 |
DisclosureSEC source: 0000915389-25-000048 · wk-form4_1740431994.xml · derivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,725 Underlying: Common Stock · 12,725 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:04 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 2,077 | $103.47 | $214,907.19 |
DisclosureSEC source: 0000915389-25-000024 · wk-form4_1740085467.xml · nonDerivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,731 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout of performance shares. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:04 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 8,405 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000024 · wk-form4_1740085467.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,808 F1 · shares: Payout of performance shares awarded at beginning of three-year (2022-2024) performance period. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,456 | $0.00 Strike: $61.51 | $0.00 |
DisclosureSEC source: 0000915389-24-000236 · wk-form4_1732741733.xml · derivative · entry 4 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,456 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 4,456 | $105.84 | $471,623.04 |
DisclosureSEC source: 0000915389-24-000236 · wk-form4_1732741733.xml · nonDerivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,403 Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 4,456 | $61.51 | $274,088.56 |
DisclosureSEC source: 0000915389-24-000236 · wk-form4_1732741733.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 2,482 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000081 · wk-form4_1709240609.xml · derivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,482 Underlying: Common Stock · 2,482 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 27, 2027, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 27, 2027, subject to continued employment. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 12,264 | $0.00 Strike: $86.15 | $0.00 |
DisclosureSEC source: 0000915389-24-000081 · wk-form4_1709240609.xml · derivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,264 Underlying: Common Stock · 12,264 shares Expires 2034-02-26 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 27, 2025, February 27, 2026, and February 27, 2027, respectively. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:11 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 519 | $82.12 | $42,620.28 |
DisclosureSEC source: 0000915389-24-000035 · wk-form4_1708117853.xml · nonDerivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,434 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:11 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000035 · wk-form4_1708117853.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,953 F1 · shares: Payout under performance shares awarded at beginning of three-year (2021-2023) performance period. Read SEC document |
| February 14, 2024 Filed Feb 21, 2024 21:05 UTC Amendment | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 550 | $82.12 | $45,166.00 |
DisclosureSEC source: 0000915389-24-000061 · wk-form4a_1708549519.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,403 F1 · shares: This amendment corrects the Form 4 filed on February 16, 2024 with respect to the number of shares of common stock withheld in payment of tax liability incident to the payout of performance shares for the 2021-2023 performance period. The balance of shares beneficially owned following the reported transaction has also been corrected. F1 · balance_after: This amendment corrects the Form 4 filed on February 16, 2024 with respect to the number of shares of common stock withheld in payment of tax liability incident to the payout of performance shares for the 2021-2023 performance period. The balance of shares beneficially owned following the reported transaction has also been corrected. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 21:16 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 12,942 | $0.00 Strike: $83.84 | $0.00 |
DisclosureSEC source: 0000915389-23-000051 · wf-form4_167761896659341.xml · derivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,942 Underlying: Common Stock · 12,942 shares Expires 2033-02-23 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 24, 2024, February 24, 2025, and February 24, 2026, respectively. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:22 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 1,900 | $86.89 | $165,091.00 |
DisclosureSEC source: 0000915389-23-000033 · wf-form4_167701450609712.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,877 Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:11 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 834 | $89.09 | $74,301.06 |
DisclosureSEC source: 0000915389-23-000029 · wf-form4_167666828658534.xml · nonDerivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:11 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 3,343 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-23-000029 · wf-form4_167666828658534.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP, Regions & Chf SupChn Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,611 F1 · shares: Payout under performance shares awarded at beginning of three-year (2020-2022) performance period. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 13:24 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 10,378 | $0.00 Strike: $120.80 | $0.00 |
DisclosureSEC source: 0000899243-22-008265 · doc4.xml · derivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP SupChn,Regions& Transform 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,378 Underlying: Common Stock · 10,378 shares Expires 2032-02-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 25, 2023, February 25, 2024, and February 25, 2025, respectively. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:16 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 757 | $119.03 | $90,105.71 |
DisclosureSEC source: 0000899243-22-007840 · doc4.xml · nonDerivative · entry 2 McAlindon Julie A. · CIK 0001571482 · SVP SupChn,Regions&Transform 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,268 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:16 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-007840 · doc4.xml · nonDerivative · entry 1 McAlindon Julie A. · CIK 0001571482 · SVP SupChn,Regions&Transform 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,025 F1 · shares: Payout under performance shares awarded at beginning of three-year (2019-2021) performance period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.